Ann Arbor-based NanoBio Corp. has published data from its ferret influenza vaccine study of its NB-1008 product in the July 2011 issue of Clinical Vaccine Immunology by the American Society of ...

ANN ARBOR -- NanoBio Corp. Thursday announced a preclinical collaboration with a subsidiary of Merck & Co. Inc. focused on the development of a vaccine for Respiratory Syncytial Virus (RSV). The ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Ann Arbor-based NanoBio Corp., considered by many as ...

NanoBio(R) Corporation today announced the promotion of David Peralta to chief executive officer. Mr. Peralta, who previously served as the company’s chief operating and financial officer, replaces ...

There has been a recent eruption (sorry 'bout that) of research geared toward discovering the first vaccine to treat and/or prevent genital herpes. You can add one more contender — Michigan-based ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. NanoBio Corp. said today that it has been granted a ...

Nanoemulsion Adjuvanted Vaccines Continue to Demonstrate Positive Pre-Clinical Results in Genital Herpes, HIV and Chlamydia ANN ARBOR, Mich., (December 2, 2015) – NanoBio Corporation, a ...

ANN ARBOR, Mich. (October 13, 2009) -NanoBio Corporation today announced an award from the National Institute of Allergy and Infectious Diseases, a Division of The National Institute of Health, to ...

Anti-infection and dermatology drug company NanoBio Corp. raked in $11 million in series C financing from its existing lineup of investors, bringing its total to $130 million, half of which has come ...

ANN ARBOR, Mich. (April 19, 2010) - NanoBio® Corporation today announced an initiative to develop an intranasal vaccine for the treatment of hepatitis B (HBV). NanoBio and the University of Michigan's ...

ANN ARBOR, Mich., May 7, 2018 /PRNewswire/ -- NanoBio Corporation, a clinical-stage biopharmaceutical company, today announced that it has changed its corporate name to BlueWillow Biologics ® in ...

ANN ARBOR, Mich., Oct. 8, 2020 /PRNewswire/ -- BlueWillow Biologics ®, a clinical-stage biopharmaceutical company, is pleased to announce the launch of NanoBio ® Protect (NanoBio ®), the first alcohol ...